Multiple myeloma, a cancer of the bone marrow, remains difficult to treat despite modern CAR T cell therapies. In recent research, a team led by Dr. Armin Rehm presents an improved immunotherapy that ...
CAR-T therapy is a major advance in cancer care, but high costs and centralized global manufacturing limit access.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback